1
|
Mendes MA, Smith JP, Marin JK, Bounthavong M, Lau MK, Miranda JL, Gray D, Brown M, Hauser P. Reducing Benzodiazepine Prescribing in Older Veterans: A Direct-to-Consumer Educational Brochure. Fed Pract 2018; 35:36-43. [PMID: 30766385 PMCID: PMC6366792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
This quality improvement project used an educational brochure to help older veterans reduce their benzodiazepine use.
Collapse
Affiliation(s)
- Margaret A Mendes
- is a Pharmacist at the VA San Diego Healthcare System in California and Program Director of VISN 22 Academic Detailing Program at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is Program Director of VISN 19 Academic Detailing Program in Glendale, Colorado. is a VISN Pharmacy Benefits Management Data and Program Manager at the VISN 21 Network Office on Mare Island, California. and are National Program Managers at the VHA Pharmacy Benefits Management Academic Detailing Service in Washington, DC. is a Research Assistant in the Division of Mental Health at the Long Beach VAMC in California. was the VISN 22 Pharmacy Lead at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is a Program Manager for the VISN 22 Academic Detailing Program. is the Director of the National VA Telemental Health Hub Long Beach and Psychiatrist in the Division of Mental Health at the Long Beach VAMC; Clinical Professor in the Department of Psychiatry and Human Behavior at the University of California in Irvine; and Clinical Professor in the Department of Psychiatry at the University of California in San Diego
| | - Jason P Smith
- is a Pharmacist at the VA San Diego Healthcare System in California and Program Director of VISN 22 Academic Detailing Program at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is Program Director of VISN 19 Academic Detailing Program in Glendale, Colorado. is a VISN Pharmacy Benefits Management Data and Program Manager at the VISN 21 Network Office on Mare Island, California. and are National Program Managers at the VHA Pharmacy Benefits Management Academic Detailing Service in Washington, DC. is a Research Assistant in the Division of Mental Health at the Long Beach VAMC in California. was the VISN 22 Pharmacy Lead at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is a Program Manager for the VISN 22 Academic Detailing Program. is the Director of the National VA Telemental Health Hub Long Beach and Psychiatrist in the Division of Mental Health at the Long Beach VAMC; Clinical Professor in the Department of Psychiatry and Human Behavior at the University of California in Irvine; and Clinical Professor in the Department of Psychiatry at the University of California in San Diego
| | - Jennifer Kryskalla Marin
- is a Pharmacist at the VA San Diego Healthcare System in California and Program Director of VISN 22 Academic Detailing Program at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is Program Director of VISN 19 Academic Detailing Program in Glendale, Colorado. is a VISN Pharmacy Benefits Management Data and Program Manager at the VISN 21 Network Office on Mare Island, California. and are National Program Managers at the VHA Pharmacy Benefits Management Academic Detailing Service in Washington, DC. is a Research Assistant in the Division of Mental Health at the Long Beach VAMC in California. was the VISN 22 Pharmacy Lead at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is a Program Manager for the VISN 22 Academic Detailing Program. is the Director of the National VA Telemental Health Hub Long Beach and Psychiatrist in the Division of Mental Health at the Long Beach VAMC; Clinical Professor in the Department of Psychiatry and Human Behavior at the University of California in Irvine; and Clinical Professor in the Department of Psychiatry at the University of California in San Diego
| | - Mark Bounthavong
- is a Pharmacist at the VA San Diego Healthcare System in California and Program Director of VISN 22 Academic Detailing Program at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is Program Director of VISN 19 Academic Detailing Program in Glendale, Colorado. is a VISN Pharmacy Benefits Management Data and Program Manager at the VISN 21 Network Office on Mare Island, California. and are National Program Managers at the VHA Pharmacy Benefits Management Academic Detailing Service in Washington, DC. is a Research Assistant in the Division of Mental Health at the Long Beach VAMC in California. was the VISN 22 Pharmacy Lead at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is a Program Manager for the VISN 22 Academic Detailing Program. is the Director of the National VA Telemental Health Hub Long Beach and Psychiatrist in the Division of Mental Health at the Long Beach VAMC; Clinical Professor in the Department of Psychiatry and Human Behavior at the University of California in Irvine; and Clinical Professor in the Department of Psychiatry at the University of California in San Diego
| | - Marcos K Lau
- is a Pharmacist at the VA San Diego Healthcare System in California and Program Director of VISN 22 Academic Detailing Program at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is Program Director of VISN 19 Academic Detailing Program in Glendale, Colorado. is a VISN Pharmacy Benefits Management Data and Program Manager at the VISN 21 Network Office on Mare Island, California. and are National Program Managers at the VHA Pharmacy Benefits Management Academic Detailing Service in Washington, DC. is a Research Assistant in the Division of Mental Health at the Long Beach VAMC in California. was the VISN 22 Pharmacy Lead at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is a Program Manager for the VISN 22 Academic Detailing Program. is the Director of the National VA Telemental Health Hub Long Beach and Psychiatrist in the Division of Mental Health at the Long Beach VAMC; Clinical Professor in the Department of Psychiatry and Human Behavior at the University of California in Irvine; and Clinical Professor in the Department of Psychiatry at the University of California in San Diego
| | - Juan L Miranda
- is a Pharmacist at the VA San Diego Healthcare System in California and Program Director of VISN 22 Academic Detailing Program at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is Program Director of VISN 19 Academic Detailing Program in Glendale, Colorado. is a VISN Pharmacy Benefits Management Data and Program Manager at the VISN 21 Network Office on Mare Island, California. and are National Program Managers at the VHA Pharmacy Benefits Management Academic Detailing Service in Washington, DC. is a Research Assistant in the Division of Mental Health at the Long Beach VAMC in California. was the VISN 22 Pharmacy Lead at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is a Program Manager for the VISN 22 Academic Detailing Program. is the Director of the National VA Telemental Health Hub Long Beach and Psychiatrist in the Division of Mental Health at the Long Beach VAMC; Clinical Professor in the Department of Psychiatry and Human Behavior at the University of California in Irvine; and Clinical Professor in the Department of Psychiatry at the University of California in San Diego
| | - David Gray
- is a Pharmacist at the VA San Diego Healthcare System in California and Program Director of VISN 22 Academic Detailing Program at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is Program Director of VISN 19 Academic Detailing Program in Glendale, Colorado. is a VISN Pharmacy Benefits Management Data and Program Manager at the VISN 21 Network Office on Mare Island, California. and are National Program Managers at the VHA Pharmacy Benefits Management Academic Detailing Service in Washington, DC. is a Research Assistant in the Division of Mental Health at the Long Beach VAMC in California. was the VISN 22 Pharmacy Lead at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is a Program Manager for the VISN 22 Academic Detailing Program. is the Director of the National VA Telemental Health Hub Long Beach and Psychiatrist in the Division of Mental Health at the Long Beach VAMC; Clinical Professor in the Department of Psychiatry and Human Behavior at the University of California in Irvine; and Clinical Professor in the Department of Psychiatry at the University of California in San Diego
| | - Maria Brown
- is a Pharmacist at the VA San Diego Healthcare System in California and Program Director of VISN 22 Academic Detailing Program at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is Program Director of VISN 19 Academic Detailing Program in Glendale, Colorado. is a VISN Pharmacy Benefits Management Data and Program Manager at the VISN 21 Network Office on Mare Island, California. and are National Program Managers at the VHA Pharmacy Benefits Management Academic Detailing Service in Washington, DC. is a Research Assistant in the Division of Mental Health at the Long Beach VAMC in California. was the VISN 22 Pharmacy Lead at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is a Program Manager for the VISN 22 Academic Detailing Program. is the Director of the National VA Telemental Health Hub Long Beach and Psychiatrist in the Division of Mental Health at the Long Beach VAMC; Clinical Professor in the Department of Psychiatry and Human Behavior at the University of California in Irvine; and Clinical Professor in the Department of Psychiatry at the University of California in San Diego
| | - Peter Hauser
- is a Pharmacist at the VA San Diego Healthcare System in California and Program Director of VISN 22 Academic Detailing Program at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is Program Director of VISN 19 Academic Detailing Program in Glendale, Colorado. is a VISN Pharmacy Benefits Management Data and Program Manager at the VISN 21 Network Office on Mare Island, California. and are National Program Managers at the VHA Pharmacy Benefits Management Academic Detailing Service in Washington, DC. is a Research Assistant in the Division of Mental Health at the Long Beach VAMC in California. was the VISN 22 Pharmacy Lead at the Veterans Integrated Systems Network (VISN) 22 Network Office in Long Beach, California. is a Program Manager for the VISN 22 Academic Detailing Program. is the Director of the National VA Telemental Health Hub Long Beach and Psychiatrist in the Division of Mental Health at the Long Beach VAMC; Clinical Professor in the Department of Psychiatry and Human Behavior at the University of California in Irvine; and Clinical Professor in the Department of Psychiatry at the University of California in San Diego
| |
Collapse
|
2
|
DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers MED, Savani BN, Shaw BE. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplant 2016; 52:173-182. [PMID: 27548466 DOI: 10.1038/bmt.2016.203] [Citation(s) in RCA: 42] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2016] [Revised: 05/08/2016] [Accepted: 05/09/2016] [Indexed: 12/12/2022]
Abstract
Metabolic syndrome (MetS) is a constellation of cardiovascular risk factors that increases the risk of cardiovascular disease, diabetes mellitus and all cause mortality. Long-term survivors of hematopoietic cell transplantation (HCT) have a substantial risk of developing MetS and cardiovascular disease, with the estimated prevalence of MetS being 31-49% among HCT recipients. Although MetS has not yet been proven to impact cardiovascular risk after HCT, an understanding of the incidence and risk factors for MetS in HCT recipients can provide the foundation to evaluate screening guidelines and develop interventions that may mitigate cardiovascular-related mortality. A working group was established through the Center for International Blood and Marrow Transplant Research and the European Group for Blood and Marrow Transplantation with the goal of reviewing literature and recommend practices appropriate to HCT recipients. Here we deliver consensus recommendations to help clinicians provide screening and preventive care for MetS and cardiovascular disease among HCT recipients. All HCT survivors should be advised of the risks of MetS and encouraged to undergo recommended screening based on their predisposition and ongoing risk factors.
Collapse
Affiliation(s)
- Z DeFilipp
- Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA
| | - R F Duarte
- Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
| | - J A Snowden
- Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust and Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK
| | - N S Majhail
- Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA
| | - D M Greenfield
- Specialized Cancer Services, Sheffield Teaching Hospital NHS Foundation Trust, Shefflied, UK
| | - J L Miranda
- Department of Medicine, Reina Sofia University Hospital, Maimonides Institute for Biomedical Research at Cordoba (IMIBIC), University of Cordoba, CIBER Fisiopatología Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain
| | - M Arat
- Florence Nightingale Sisli Hospital, Hematopoietic Stem Cell Transplantation Unit, Istanbul, Turkey
| | - K S Baker
- Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - L J Burns
- National Marrow Donor Program, University of Minnesota, Minneapolis, MN, USA
| | - C N Duncan
- Pediatric Stem Cell Transplant, Dana-Farber Cancer Institute, Boston, MA, USA
| | - M Gilleece
- Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - G A Hale
- All Children's Hospital, John Hopkins Medicine, St. Petersburg, FL, USA
| | - M Hamadani
- Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA
| | - B K Hamilton
- Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA
| | - W J Hogan
- Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
| | - J W Hsu
- Division of Hematology & Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA
| | - Y Inamoto
- Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
| | - R T Kamble
- Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA
| | - M T Lupo-Stanghellini
- Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milano, Italy
| | - A K Malone
- Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA
| | - P McCarthy
- Department of Medicine, Roswell Park Cancer Institute, BMT Program, Buffalo, NY, USA
| | - M Mohty
- University Pierre & Marie Curie, Paris, France.,Hopital Saint-Antoine, AP-HP, Paris, France.,INSERM UMRs 938, Paris, France
| | - M Norkin
- Division of Hematology & Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA
| | - P Paplham
- Department of Medicine, Roswell Park Cancer Institute, BMT Program, Buffalo, NY, USA
| | - M Ramanathan
- Department Hematology, Oncology and Bone Marrow Transplant, UMass Memorial Medical Center, Worcester, MA, USA
| | - J M Richart
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University, St. Louis, MO, USA
| | | | - H C Schouten
- Maastricht University Medical Center, Maastricht, The Netherlands
| | - H Schoemans
- Department of Hematology, University Hospital Leuven and KU Leuven, Leuven, Belgium
| | - A Seber
- Hospital Samaritano, Sao Paulo, Brazil.,Associação da Medula Ossea - AMEO, Sao Paulo, Brazil
| | - A Steinberg
- Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA
| | - B M Wirk
- Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY, USA
| | - W A Wood
- Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
| | - M Battiwalla
- Hematology Branch, National Institutes of Health, Bethesda, MD, USA
| | - M E D Flowers
- Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - B N Savani
- Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
| | - B E Shaw
- Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA
| |
Collapse
|
4
|
Castro P, Miranda JL, Gómez P, Escalante DM, Segura FL, Martín A, Fuentes F, Blanco A, Ordovás JM, Jiménez FP. Comparison of an oleic acid enriched-diet vs NCEP-I diet on LDL susceptibility to oxidative modifications. Eur J Clin Nutr 2000; 54:61-7. [PMID: 10694774 DOI: 10.1038/sj.ejcn.1600894] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVE The objective of this trial was to compare the effect on the susceptibility of plasma Low Density Lipoprotein (LDL) to oxidative modifications of consumption of two oleic rich diets, prepared with two different plant oils, virgin olive oil (OL)1 and refined high monounsaturated fatty acids (MUFA sunflower oil (SU)), with the susceptibility of plasma LDL to oxidation after an National Cholesterol Education Program step 1 (NCEP-I) phase diet. DESIGN A randomized crossover design. SUBJECTS AND INTERVENTIONS Twenty-two healthy normolipidemic young males consumed an NCEP-I diet for a 4-week period. Subjects were then assigned to two diets each of 4-weeks duration. Group one was placed on an olive oil enriched diet (40% fat, 22% MUFA) followed by a 4-week period of a MUFA diet enriched in sunflower oil (40% fat, 22% MUFA). In group two, the order of the diets was reversed. RESULTS Both MUFA diets induced a decrease in saturated (14:0, 16:0, and 18:0) and an increase in monounsaturated and polyunsaturated n-6 (18:2, 20:3, and 20:5) plasma LDL-phospholipid fatty acids, compared to the NCEP-I diet (P<0.01). No significant differences in lag times were observed between the olive oil and the NCEP-I diet periods. However there was a greater inhibition time (P<0.001) when subjects consumed the MUFA rich sunflower oil diet compared to the NCEP-I diet. These differences were probably related to the relative enrichment of plasma LDL particles in alpha-tocopherol due to the high vitamin E content of the MUFA-rich sunflower oil. Indeed, the alpha-tocopherol content was positively correlated with lag time (r=0.338; P<0.008). CONCLUSION Our findings suggest that changes in plasma LDL alpha-tocopherol content with practical solid-food diets can decrease its susceptibility to oxidation. SPONSORSHIP This work has been supported by grants from the Investigaciones de la Seguridad Social (FIS 92/0182, to Francisco Pérez Jiménez); and from Koype Co, Andújar, Jaén, Spain. European Journal of Clinical Nutrition (2000) 54, 61-67
Collapse
Affiliation(s)
- P Castro
- Lipids Research Unit, Hospital University Reina Sofia, Medical School, University of Córdoba, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|